Literature DB >> 26696402

Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study.

Matthias Schiedel1, Tobias Rumpf1, Berin Karaman2, Attila Lehotzky3, Judit Oláh3, Stefan Gerhardt4, Judit Ovádi3, Wolfgang Sippl2, Oliver Einsle4, Manfred Jung1.   

Abstract

Sirtuins are NAD(+)-dependent protein deacylases that cleave off acetyl but also other acyl groups from the ε-amino group of lysines in histones and other substrate proteins. Dysregulation of human Sirt2 (hSirt2) activity has been associated with the pathogenesis of cancer, inflammation, and neurodegeneration, which makes the modulation of hSirt2 activity a promising strategy for pharmaceutical intervention. The sirtuin rearranging ligands (SirReals) have recently been discovered by us as highly potent and isotype-selective hSirt2 inhibitors. Here, we present a well-defined structure-activity relationship study, which rationalizes the unique features of the SirReals and probes the limits of modifications on this scaffold regarding inhibitor potency. Moreover, we present a crystal structure of hSirt2 in complex with an optimized SirReal derivative that exhibits an improved in vitro activity. Lastly, we show cellular hyperacetylation of the hSirt2 targeted tubulin caused by our improved lead structure.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26696402     DOI: 10.1021/acs.jmedchem.5b01517

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  A Small-Molecule SIRT2 Inhibitor That Promotes K-Ras4a Lysine Fatty-Acylation.

Authors:  Nicole A Spiegelman; Jun Young Hong; Jing Hu; Hui Jing; Miao Wang; Ian R Price; Ji Cao; Min Yang; Xiaoyu Zhang; Hening Lin
Journal:  ChemMedChem       Date:  2019-02-25       Impact factor: 3.466

2.  Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.

Authors:  Norio Kudo; Akihiro Ito; Mayumi Arata; Akiko Nakata; Minoru Yoshida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

3.  New chemical tools for probing activity and inhibition of the NAD+-dependent lysine deacylase sirtuin 2.

Authors:  Sören Swyter; Matthias Schiedel; Daria Monaldi; Sándor Szunyogh; Attila Lehotzky; Tobias Rumpf; Judit Ovádi; Wolfgang Sippl; Manfred Jung
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

4.  Piperazine tethered bergenin heterocyclic hybrids: design, synthesis, anticancer activity, and molecular docking studies.

Authors:  Banoth Venkateswara Rao; P Pavan Kumar; Vaikundamoorthy Ramalingam; G Karthik; Sai Balaji Andugulapati; K Suresh Babu
Journal:  RSC Med Chem       Date:  2022-05-31

Review 5.  Sirtuin modulators: past, present, and future perspectives.

Authors:  Francesco Fiorentino; Nicola Mautone; Martina Menna; Francesca D'Acunzo; Antonello Mai; Dante Rotili
Journal:  Future Med Chem       Date:  2022-05-18       Impact factor: 4.767

6.  Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing.

Authors:  Berin Karaman; Zayan Alhalabi; Sören Swyter; Shetonde O Mihigo; Kerstin Andrae-Marobela; Manfred Jung; Wolfgang Sippl; Fidele Ntie-Kang
Journal:  Molecules       Date:  2018-02-14       Impact factor: 4.411

7.  The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition.

Authors:  Michael Schnekenburger; Véronique Mathieu; Florence Lefranc; Jun Young Jang; Marco Masi; Anake Kijjoa; Antonio Evidente; Hyun-Jung Kim; Robert Kiss; Mario Dicato; Byung Woo Han; Marc Diederich
Journal:  Molecules       Date:  2018-02-05       Impact factor: 4.411

8.  Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.

Authors:  Sandeep Sundriyal; Sébastien Moniot; Zimam Mahmud; Shang Yao; Paolo Di Fruscia; Christopher R Reynolds; David T Dexter; Michael J E Sternberg; Eric W-F Lam; Clemens Steegborn; Matthew J Fuchter
Journal:  J Med Chem       Date:  2017-02-15       Impact factor: 7.446

Review 9.  Sirtuin functions and modulation: from chemistry to the clinic.

Authors:  Vincenzo Carafa; Dante Rotili; Mariantonietta Forgione; Francesca Cuomo; Enrica Serretiello; Gebremedhin Solomon Hailu; Elina Jarho; Maija Lahtela-Kakkonen; Antonello Mai; Lucia Altucci
Journal:  Clin Epigenetics       Date:  2016-05-25       Impact factor: 6.551

10.  Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.

Authors:  Adél Szabó; Judit Oláh; Sándor Szunyogh; Attila Lehotzky; Tibor Szénási; Marianna Csaplár; Matthias Schiedel; Péter Lőw; Manfred Jung; Judit Ovádi
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.